INSPIRE MEDICAL SYSTEMS INC (INSP) Stock Analyst Earnings Estimates
NYSE:INSP - New York Stock Exchange, Inc. - US4577301090 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 407.9M 74.76% | 624.799M 53.17% | 802.804M 28.49% | 968.58M 20.65% | 1.138B 17.49% | 1.325B 16.43% | 1.541B 16.30% | 1.74B 12.91% | 1.964B 12.87% | 2.107B 7.28% | 2.395B 13.67% | |
| EBITDA YoY % growth | -45.74M -18.25% | -37.425M 18.18% | 42.633M 213.92% | 62.833M 47.38% | 120.75M 92.18% | 277.34M 129.68% | 389.13M 40.31% | 458.9M 17.93% | 531.83M 15.89% | 617.3M 16.07% | N/A | |
| EBIT YoY % growth | -47.6M -19.30% | -40.271M 15.40% | 36.083M 189.60% | 55.846M 54.77% | 103.99M 86.21% | 160.82M 54.65% | 215.93M 34.27% | 298.18M 38.09% | 360.88M 21.03% | 448.09M 24.17% | 631.38M 40.90% | |
| Operating Margin | -11.67% | -6.45% | 4.49% | 5.77% | 9.14% | 12.14% | 14.01% | 17.14% | 18.37% | 21.27% | 26.36% | |
| EPS YoY % growth | -1.64 -5.81% | -0.74 54.88% | 1.73 333.78% | 2.21 27.77% | 3.26 47.46% | 4.70 44.05% | 5.38 14.48% | 7.02 30.61% | 8.79 25.13% | 8.52 -3.06% | N/A |
All data in USD
| Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.25 26.94% | 0.42 30.50% | 0.69 14.93% | 1.34 16.20% | 0.33 232.43% | 0.68 61.82% | 0.82 19.44% | 1.17 -12.41% |
| Revenue Q2Q % growth | 199.08M 21.38% | 232.63M 18.76% | 246.72M 21.42% | 289.83M 20.90% | 238.76M 19.93% | 267.25M 14.88% | 286.14M 15.98% | 341.18M 17.72% |
| EBITDA Q2Q % growth | -7.859M 45.34% | 15.802M 115.84% | 26.118M 42.02% | 47.114M 22.58% | 9.925M 226.29% | 18.217M 15.28% | 15.779M -39.59% | 30.202M -35.90% |
| EBIT Q2Q % growth | -12.44M 18.26% | 9.414M 84.62% | 18.233M 27.34% | 40.589M 27.30% | 5.355M 143.05% | 16.823M 78.70% | 21.55M 18.19% | 35.141M -13.42% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | 1.15 134.69% | 0.75 | 0.40 | 54.07% |
| Q3 2024 Q2Q % growth | 0.60 306.90% | 0.08 | 0.52 | 681.29% |
| Q2 2024 Q2Q % growth | 0.32 178.05% | -0.14 | 0.46 | 325.04% |
| Q1 2024 Q2Q % growth | -0.34 35.85% | -0.66 | 0.32 | 48.86% |
| Q4 2023 Q2Q % growth | 0.49 390.00% | -0.09 | 0.58 | 642.33% |
| Q3 2023 Q2Q % growth | -0.29 51.67% | -0.59 | 0.30 | 51.01% |
| Q2 2023 Q2Q % growth | -0.41 22.64% | -0.58 | 0.17 | 29.39% |
| Q1 2023 Q2Q % growth | -0.53 13.11% | -0.67 | 0.14 | 21.27% |
| Q4 2022 Q2Q % growth | 0.10 211.11% | -0.58 | 0.68 | 117.32% |
| Q3 2022 Q2Q % growth | -0.60 -57.89% | -0.78 | 0.18 | 23.21% |
| Q2 2022 Q2Q % growth | -0.53 -10.42% | -0.63 | 0.10 | 15.95% |
| Q1 2022 Q2Q % growth | -0.61 -1.67% | -0.81 | 0.20 | 24.87% |
| Q4 2021 Q2Q % growth | -0.09 67.86% | -0.45 | 0.36 | 79.81% |
| Q3 2021 Q2Q % growth | -0.38 2.56% | -0.63 | 0.25 | 39.38% |
| Q2 2021 Q2Q % growth | -0.48 45.45% | -0.65 | 0.17 | 26.57% |
| Q1 2021 Q2Q % growth | -0.60 10.45% | -0.67 | 0.07 | 10.87% |
| Q4 2020 Q2Q % growth | -0.28 26.32% | -0.49 | 0.21 | 43.08% |
| Q3 2020 Q2Q % growth | -0.39 -14.71% | -0.74 | 0.35 | 47.01% |
| Q2 2020 Q2Q % growth | -0.88 -175.00% | -1.12 | 0.24 | 21.57% |
| Q1 2020 Q2Q % growth | -0.67 -91.43% | -0.58 | -0.09 | -15.89% |
| Q4 2019 Q2Q % growth | -0.38 | -0.41 | 0.03 | 7.21% |
| Q3 2019 Q2Q % growth | -0.34 | -0.42 | 0.08 | 19.26% |
| Q2 2019 Q2Q % growth | -0.32 | -0.44 | 0.12 | 27.62% |
| Q1 2019 Q2Q % growth | -0.35 | -0.39 | 0.04 | 9.97% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | 239.718M 24.52% | 241.74M | -2.022M | -0.84% |
| Q3 2024 Q2Q % growth | 203.191M 32.54% | 201.55M | 1.641M | 0.81% |
| Q2 2024 Q2Q % growth | 195.885M 29.65% | 193.25M | 2.635M | 1.36% |
| Q1 2024 Q2Q % growth | 164.01M 28.24% | 164.67M | -660K | -0.40% |
| Q4 2023 Q2Q % growth | 192.508M 39.60% | 190.98M | 1.528M | 0.80% |
| Q3 2023 Q2Q % growth | 153.302M 40.39% | 157.54M | -4.238M | -2.69% |
| Q2 2023 Q2Q % growth | 151.092M 65.31% | 139.07M | 12.022M | 8.64% |
| Q1 2023 Q2Q % growth | 127.897M 84.29% | 121.69M | 6.207M | 5.10% |
| Q4 2022 Q2Q % growth | 137.9M 75.89% | 131.85M | 6.05M | 4.59% |
| Q3 2022 Q2Q % growth | 109.2M 76.99% | 96.201M | 12.999M | 13.51% |
| Q2 2022 Q2Q % growth | 91.4M 72.45% | 79.841M | 11.559M | 14.48% |
| Q1 2022 Q2Q % growth | 69.4M 71.78% | 65.454M | 3.946M | 6.03% |
| Q4 2021 Q2Q % growth | 78.4M 70.43% | 78.117M | 283K | 0.36% |
| Q3 2021 Q2Q % growth | 61.7M 72.35% | 56.725M | 4.975M | 8.77% |
| Q2 2021 Q2Q % growth | 53M 334.43% | 44.747M | 8.253M | 18.44% |
| Q1 2021 Q2Q % growth | 40.4M 89.67% | 37.678M | 2.722M | 7.22% |
| Q4 2020 Q2Q % growth | 46M 71.00% | 41.895M | 4.105M | 9.80% |
| Q3 2020 Q2Q % growth | 35.8M 71.29% | 23.203M | 12.597M | 54.29% |
| Q2 2020 Q2Q % growth | 12.2M -32.22% | 8.009M | 4.191M | 52.33% |
| Q1 2020 Q2Q % growth | 21.3M 30.67% | 21.688M | -388K | -1.79% |
| Q4 2019 Q2Q % growth | 26.9M | 24.32M | 2.58M | 10.61% |
| Q3 2019 Q2Q % growth | 20.9M | 19.561M | 1.339M | 6.85% |
| Q2 2019 Q2Q % growth | 18M | 17.008M | 992K | 5.83% |
| Q1 2019 Q2Q % growth | 16.3M | 15.294M | 1.006M | 6.58% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -127.3% | 2.98% | 8.61% | 9.67% |
| Revenue | -2.29% | -3.41% | 0.01% | -0.11% |